Oceanaa Biotek Industries Ltd.

Feb 12, 2020 18:24 Source: BSE

Oceanaa Biotek Industries - Financial Results For Quarter And Nine Months Ended On 31St December, 2019

The Company hereby submits the Standalone un-audited financial results and limited review report for Quarter and nine months ended on 31st December, 2019 Kindly update the above in your records.

Jan 30, 2020 16:18 Source: BSE

Oceanaa Biotek Industries - Board Meeting Intimation for Considering And Approving The Un-Audited (Limited Reviewed) Standalone Financial Results For The Quarter Ended On December 31, 2019.

Oceanaa Biotek Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2020 ,inter alia, to consider and approve the Un-audited (limited reviewed) Standalone Financial Results for the Quarter ended on December 31, 2019. Further, in terms of the Company''''s Code of Conduct for Prevention of Insider Trading, read with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window for trading in the Company''''s securities for all the connected/designated persons has already been closed from Wednesday, January 01, 2020 till the completion of 48 hours after the declaration of financial results of the Company, i.e. close hours of Friday, February 14, 2020 (both days inclusive). Kindly take this on your records.

Jan 22, 2020 14:52 Source: BSE

Oceanaa Biotek Industries - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

In reference to the above captioned regulation, we hereby submit the Certificate received from our RTA Bigshare Services Pvt Ltd. Kindly take the same on your records.

Jan 17, 2020 14:19 Source: BSE

Oceanaa Biotek Industries - Shareholding for the Period Ended December 31, 2019

Oceanaa Biotek Industries Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here

Jan 10, 2020 16:36 Source: BSE

Oceanaa Biotek Industries - Announcement under Regulation 30 (LODR)-Change in Registered Office Address

With reference to the captioned subject and pursuant to Regulation 30 and other applicable regulations of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at their meeting held today on 10th January, 2020 has approved the Shifting of Registered Office of the Company from 4B-1 Eastern Portion, 4th Floor, Centre Point Apartment, Sadhullah Street, T Nagar - 600017, Tamil Nadu to FLAT NO.C-4, CEEBROS APARTMENTS. NO.2, SARAVANA STREET, T.NAGAR, CHENNAI-600017, TAMILNADU Kindly take this in your records.

Jan 09, 2020 10:36 Source: BSE

Oceanaa Biotek Industries - Statement Of Investor Complaints For The Quarter Ended December 2019

Jan 04, 2020 12:09 Source: BSE

Oceanaa Biotek Industries - Appointment of Company Secretary and Compliance Officer

With reference to the captioned subject and subject to Regulation 30 and other applicable regulations of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we wish to Inform you Ms. Chaitra G S, has been appointed as Company Secretary and Compliance Officer of the company pursuant to Section 203 of the Companies Act, 2013 and Regulation 6 (1) of the Securities and Exchange Board of India (Listing Obligation & Disclosure Requirements) Regulations, 2015. Kindly take the above on your records.

Dec 31, 2019 10:23 Source: BSE

Oceanaa Biotek Industries - Clarification-Price Movement

With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Oceanaa Biotek Industries Ltd has submitted to BSE a copy of Clarification. Kindly update the same in your records.

Dec 26, 2019 20:22 Source: BSE

Oceanaa Biotek Industries - Clarification sought from Oceanaa Biotek Industries Ltd

The Exchange has sought clarification from Oceanaa Biotek Industries Ltd on 26th December, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

Dec 04, 2019 15:17 Source: BSE

Oceanaa Biotek Industries - Submission Of Revised Standalone Unaudited Financial Results For The Quarter And Half Yearly Ended On 30Th September, 2019

With reference to your e-mail dated 03rd December, 2019 regarding the discrepancies in Standalone financial results for the Quarter and half yearly ended on 30th September, 2019 - ''Cash Flow Statement for Standalone Results not received in Pdf'' In this regard, we hereby furnish the Revised Standalone Unaudited Financial Results for the Quarter and half yearly ended on 30th September, 2019, which includes Cash Flow Statement.